Skip to main content
. 2016 Aug 22;7(40):66287–66298. doi: 10.18632/oncotarget.11507

Figure 2. BCR-ABL/NF-κB crosstalk.

Figure 2

Numerous pathways, including Ras, MEKK1, c-Jun N-terminal kinase (JNK) and protein kinase D2 (PKD2) are activated by the Bcr-Abl and converge on NF-κB activation. NF-κB activation is also under the regulation of osteopontin or CUEDC2, as indicated.